Should the U.S. Prohibit Reproductive Cloning?
By Tim Sandle,
Digital Journal
| 04. 18. 2014
[Quotes CGS's Marcy Darnovsky]
Untitled Document
Researchers have produced stem cell lines using somatic cell nuclear transfer (SCNT) from cells, making human reproductive cloning more technically feasible. Is this a good idea?
Not according to Marcy Darnovsky, PhD, executive director of the Center for Genetics and Society, a public interest organization based in Berkeley, California.
Talking to the Digital Journal, Darnovsky said: "No one wants to wake up to headlines that a rogue fertility doctor or scientist initiated a pregnancy with a cloned human embryo."
The Center for Genetics and Society (CGS) is a non-profit public affairs and policy advocacy organization working to encourage responsible uses and effective societal governance of human genetic and reproductive biotechnologies.
The basis of Darnovsky's concern relates to a study
published in the journal
Cell Stem Cell. In the journal, researchers report that they have produced stem cell lines using somatic cell nuclear transfer (SCNT) from cells taken from two adult men. The aim of this work is to produce patient-specific stem cells for medical treatments. But unlike induced pluripotent stem cells, which can also be patient-specific, SCNT...
Related Articles
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
By Julia Métraux, Mother Jones [cites CGS' Katie Hasson] | 07.07.2026
During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...
By Emily Baumgaertner Nunn, The New York Times | 06.30.2026
A research program at the National Institutes of Health released the world’s largest database of human genomes and paired them with clinical data, officials announced Tuesday, paving the way for a new era of study in personalized medicine.
The All...